Always calculate and report the correct number of units based on the actual dose administered as documented in the medication administration record (MAR)
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
Several autoimmune diseases can make it harder for your body to absorb B12, including pernicious anemia
While retatrutide Phase 2 data showed improvements in cardiovascular risk markers, individual responses vary, and new cardiac symptoms during any peptide protocol should be evaluated immediately
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)